{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:02:07Z","timestamp":1795017727478,"version":"4.10.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012639","name":"METAvivor","doi-asserted-by":"publisher","award":["No. 2018A020560"],"award-info":[{"award-number":["No. 2018A020560"]}],"id":[{"id":"10.13039\/100012639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005292","name":"Brigham and Women&apos;s Hospital","doi-asserted-by":"publisher","award":["No.2019A014810"],"award-info":[{"award-number":["No.2019A014810"]}],"id":[{"id":"10.13039\/100005292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Protecting the whole small intestine from radiation-induced intestinal injury during the radiotherapy of abdominal or pelvic solid tumors remains an unmet clinical need. Amifostine is a promising selective radioprotector for normal tissues. However, its oral application in intestinal radioprotection remains challenging. Herein, we use microalga\n                    <jats:italic>Spirulina platensis<\/jats:italic>\n                    as a microcarrier of Amifostine to construct an oral delivery system. The system shows comprehensive drug accumulation and effective radioprotection in the whole small intestine that is significantly superior to free drug and its enteric capsule, preventing the radiation-induced intestine injury and prolonging the survival without influencing the tumor regression. It also shows benefits on the gut microbiota homeostasis and long-term safety. Based on a readily available natural microcarrier, this work presents a convenient oral delivery system to achieve effective radioprotection for the whole small intestine, providing a competitive strategy with great clinical translation potential.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-28744-4","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T07:04:45Z","timestamp":1647500685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":243,"title":["Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy"],"prefix":"10.1038","volume":"13","author":[{"given":"Dongxiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7114-1095","authenticated-orcid":false,"given":"Xingcai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4277-3728","authenticated-orcid":false,"given":"Wei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7319-9570","authenticated-orcid":false,"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"28744_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2017.01.004","volume":"109","author":"C Allen","year":"2017","unstructured":"Allen, C., Her, S. & Jaffray, D. A. Radiotherapy for cancer: present and future. Adv. Drug Deliv. Rev. 109, 1\u20132 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"28744_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00004836-197903000-00003","volume":"1","author":"JM Novak","year":"1979","unstructured":"Novak, J. M. et al. Effects of radiation on the human gastrointestinal tract. J. Clin. Gastroenterol. 1, 9\u201339 (1979).","journal-title":"J. Clin. Gastroenterol."},{"key":"28744_CR3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(88)90872-0","volume":"2","author":"H Cole","year":"1988","unstructured":"Cole, H. Displacement of small bowel from pelvic radiation field. Lancet 2, 1341\u20131342 (1988).","journal-title":"Lancet"},{"key":"28744_CR4","doi-asserted-by":"crossref","unstructured":"Obrador, E. et al. Radioprotection and radiomitigation: from the bench to clinical practice. Biomedicines 8, 461 (2020).","DOI":"10.3390\/biomedicines8110461"},{"key":"28744_CR5","doi-asserted-by":"crossref","unstructured":"Hensley, M. L. et al. American society of clinical oncology 2008 clinical practice guideline update summary: use of chemotherapy and radiation therapy protectants. J. Oncol. Pract. 4, 277\u2013279 (2008).","DOI":"10.1200\/JOP.0868502"},{"key":"28744_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/00912700222011201","volume":"42","author":"HS Bonner","year":"2002","unstructured":"Bonner, H. S. & Shaw, L. M. New dosing regimens for amifostine: a pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion. J. Clin. Pharm. 42, 166\u2013174 (2002).","journal-title":"J. Clin. Pharm."},{"key":"28744_CR7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1211\/jpp.60.7.0001","volume":"60","author":"NP Praetorius","year":"2008","unstructured":"Praetorius, N. P. & Mandal, T. K. Alternate delivery route for amifostine as a radio-\/chemo-protecting agent. J. Pharm. Pharm. 60, 809\u2013815 (2008).","journal-title":"J. Pharm. Pharm."},{"key":"28744_CR8","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/09553000802460198","volume":"84","author":"S Pamujula","year":"2008","unstructured":"Pamujula, S., Kishore, V., Rider, B., Agrawal, K. C. & Mandal, T. K. Radioprotection in mice following oral administration of WR-1065\/PLGA nanoparticles. Int. J. Radiat. Biol. 84, 900\u2013908 (2008).","journal-title":"Int. J. Radiat. Biol."},{"key":"28744_CR9","first-page":"243","volume":"220","author":"NF Tabachnik","year":"1982","unstructured":"Tabachnik, N. F., Blackburn, P., Peterson, C. M. & Cerami, A. Protein binding of N-2-mercaptoethyl-1,3-diaminopropane via mixed disulfide formation after oral administration of WR 2721. J. Pharmacol. Exp. Ther. 220, 243\u2013246 (1982).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"28744_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ejps.2013.08.027","volume":"57","author":"P Augustijns","year":"2014","unstructured":"Augustijns, P. et al. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption. Eur. J. Pharm. Sci. 57, 322\u2013332 (2014).","journal-title":"Eur. J. Pharm. Sci."},{"key":"28744_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2165\/00003088-197702010-00004","volume":"2","author":"D Parsons","year":"1977","unstructured":"Parsons, D. Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes. Clin. Pharmacokinet. 2, 45\u201360 (1977).","journal-title":"Clin. Pharmacokinet."},{"key":"28744_CR12","doi-asserted-by":"publisher","first-page":"19787","DOI":"10.1002\/anie.202008879","volume":"59","author":"Y Xiao","year":"2020","unstructured":"Xiao, Y. et al. Oral Insulin Delivery Platforms: Strategies To Address the Biological Barriers. Angew Chem Int. Ed. 59, 19787\u201319795 (2020).","journal-title":"Angew Chem Int. Ed"},{"key":"28744_CR13","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1016\/j.matt.2021.08.011","volume":"4","author":"Y Xiao","year":"2021","unstructured":"Xiao, Y. et al. Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes. Matter 4, 3269\u20133285 (2021).","journal-title":"Matter"},{"key":"28744_CR14","doi-asserted-by":"publisher","first-page":"107536","DOI":"10.1016\/j.biotechadv.2020.107536","volume":"41","author":"Y Torres-Tiji","year":"2020","unstructured":"Torres-Tiji, Y., Fields, F. J. & Mayfield, S. P. Microalgae as a future food source. Biotechnol. Adv. 41, 107536 (2020).","journal-title":"Biotechnol. Adv."},{"key":"28744_CR15","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00204-016-1744-5","volume":"90","author":"Q Wu","year":"2016","unstructured":"Wu, Q. et al. The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview. Arch. Toxicol. 90, 1817\u20131840 (2016).","journal-title":"Arch. Toxicol."},{"key":"28744_CR16","doi-asserted-by":"crossref","unstructured":"Yu, T., Wang, Y., Chen, X., Xiong, W. & Lin, L. Spirulina platensis alleviates chronic inflammation with modulation of gut microbiota and intestinal permeability in rats fed a high\u2010fat diet. J. Cell. Mol.Med. 24, 8603\u20138613 (2020).","DOI":"10.1111\/jcmm.15489"},{"key":"28744_CR17","doi-asserted-by":"crossref","unstructured":"Guo, W. et al. Microalgae aqueous extracts exert intestinal protective effects in Caco-2 cells and dextran sodium sulphate-induced mouse colitis. Food Funct. 11, 1098\u20131109 (2020).","DOI":"10.1039\/C9FO01028A"},{"key":"28744_CR18","first-page":"242","volume":"15","author":"X Yan","year":"2019","unstructured":"Yan, X. et al. Molecular cargo delivery using multicellular magnetic microswimmers. Biotechnol. Adv. 15, 242\u2013251 (2019).","journal-title":"Biotechnol. Adv."},{"key":"28744_CR19","doi-asserted-by":"publisher","first-page":"2000819","DOI":"10.1002\/smll.202000819","volume":"16","author":"D Zhong","year":"2020","unstructured":"Zhong, D., Zhang, D., Xie, T. & Zhou, M. Biodegradable microalgae\u2010based carriers for targeted delivery and imaging\u2010guided therapy toward lung metastasis of breast cancer. Small 16, 2000819 (2020).","journal-title":"Small"},{"key":"28744_CR20","doi-asserted-by":"publisher","first-page":"eabi9265","DOI":"10.1126\/sciadv.abi9265","volume":"7","author":"D Zhong","year":"2021","unstructured":"Zhong, D. et al. Orally deliverable strategy based on microalgal biomass for intestinal disease treatment. Sci. Adv. 7, eabi9265 (2021).","journal-title":"Sci. Adv."},{"key":"28744_CR21","first-page":"517","volume":"43","author":"JW Purdie","year":"1983","unstructured":"Purdie, J. W., Inhaber, E. R., Schneider, H. & Labelle, J. L. Interaction of cultured mammalian cells with WR-2721 and its thiol, WR-1065: implications for mechanisms of radioprotection. Int. J. Radiat. Biol. 43, 517\u2013527 (1983).","journal-title":"Int. J. Radiat. Biol."},{"key":"28744_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000502979","volume":"98","author":"M King","year":"2020","unstructured":"King, M. et al. Use of amifostine for cytoprotection during radiation therapy: a review. Oncology 98, 61\u201380 (2020).","journal-title":"Oncology"},{"key":"28744_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1667\/RR3031.1","volume":"178","author":"D Schaue","year":"2012","unstructured":"Schaue, D., Kachikwu, E. L. & McBride, W. H. Cytokines in radiobiological responses: a review. Radiat. Res. 178, 505\u2013523 (2012).","journal-title":"Radiat. Res."},{"key":"28744_CR24","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0145-2126(02)00051-6","volume":"26","author":"J B\u0142asiak","year":"2002","unstructured":"B\u0142asiak, J., Gloc, E., M\u0142ynarski, W., Drzewoski, J. & Sk\u00f3rski, T. Amifostine differentially modulates DNA damage evoked by idarubicin in normal and leukemic cells. Leuk. Res. 26, 1093\u20131096 (2002).","journal-title":"Leuk. Res."},{"key":"28744_CR25","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1021\/acs.jmedchem.5b01628","volume":"59","author":"M Hofer","year":"2016","unstructured":"Hofer, M. et al. Two new faces of amifostine: protector from DNA damage in normal cells and inhibitor of DNA repair in cancer cells. J. Med. Chem. 59, 3003\u20133017 (2016).","journal-title":"J. Med. Chem."},{"key":"28744_CR26","first-page":"2","volume":"21","author":"WJVD Vijgh","year":"1994","unstructured":"Vijgh, W. J. V. D. & Peters, G. J. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (Ethyol): preclinical aspects. Semin. Oncol. 21, 2\u20137 (1994).","journal-title":"Semin. Oncol."},{"key":"28744_CR27","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3109\/02841869209083871","volume":"31","author":"CW Langberg","year":"1992","unstructured":"Langberg, C. W., Sauer, T., Reitan, J. B. & Hauer-Jensen, M. Tolerance of rat small intestine to localized single dose and fractionated irradiation. Acta Oncol. 31, 781\u2013787 (1992).","journal-title":"Acta Oncol."},{"key":"28744_CR28","doi-asserted-by":"publisher","first-page":"105019","DOI":"10.1016\/j.ejps.2019.105019","volume":"138","author":"C Maderuelo","year":"2019","unstructured":"Maderuelo, C., Lanao, J. M. & Zarzuelo, A. Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability. Eur. J. Pharm. Sci. 138, 105019 (2019).","journal-title":"Eur. J. Pharm. Sci."},{"key":"28744_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11095-018-2386-5","volume":"35","author":"K Ranganathan","year":"2018","unstructured":"Ranganathan, K. et al. Novel formulation strategy to improve the feasibility of amifostine administration. Pharm. Res. 35, 99 (2018).","journal-title":"Pharm. Res."},{"key":"28744_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1128\/MMBR.00017-08","volume":"72","author":"S Lebeer","year":"2008","unstructured":"Lebeer, S., Vanderleyden, J. & De Keersmaecker, S. C. Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 72, 728\u2013764 (2008).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"28744_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.anaerobe.2015.12.009","volume":"38","author":"L Zhou","year":"2016","unstructured":"Zhou, L., Fang, L., Sun, Y., Su, Y. & Zhu, W. Effects of the dietary protein level on the microbial composition and metabolomic profile in the hindgut of the pig. Anaerobe 38, 61\u201369 (2016).","journal-title":"Anaerobe"},{"key":"28744_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung, C., Rivera, L., Furness, J. B. & Angus, P. W. The role of the gut microbiota in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 13, 412\u2013425 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"28744_CR33","doi-asserted-by":"publisher","first-page":"9087","DOI":"10.1039\/D1FO00782C","volume":"12","author":"J Luo","year":"2021","unstructured":"Luo, J. et al. A comparative study of the effects of different fucoidans on cefoperazone-induced gut microbiota disturbance and intestinal inflammation. Food Funct. 12, 9087\u20139097 (2021).","journal-title":"Food Funct."},{"key":"28744_CR34","first-page":"129","volume":"5","author":"T Eslamparast","year":"2013","unstructured":"Eslamparast, T., Eghtesad, S., Hekmatdoost, A. & Poustchi, H. Probiotics and nonalcoholic fatty liver disease. Middle East J. Dig. Dis. 5, 129\u2013136 (2013).","journal-title":"Middle East J. Dig. Dis."},{"key":"28744_CR35","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1038\/s41386-019-0437-1","volume":"44","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. Early-life high-fat diet-induced obesity programs hippocampal development and cognitive functions via regulation of gut commensal Akkermansia muciniphila. Neuropsychopharmacology 44, 2054\u20132064 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"28744_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51361-z","volume":"9","author":"D Chandel","year":"2019","unstructured":"Chandel, D., Sharma, M., Chawla, V., Sachdeva, N. & Shukla, G. Isolation, characterization and identification of antigenotoxic and anticancerous indigenous probiotics and their prophylactic potential in experimental colon carcinogenesis. Sci. Rep. 9, 14769 (2019).","journal-title":"Sci. Rep."},{"key":"28744_CR37","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0960-9822(07)00487-3","volume":"8","author":"E Hoiczyk","year":"1998","unstructured":"Hoiczyk, E. & Baumeister, W. The junctional pore complex, a prokaryotic secretion organelle, is the molecular motor underlying gliding motility in cyanobacteria. Curr. Biol. 8, 1161\u20131168 (1998).","journal-title":"Curr. Biol."},{"key":"28744_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jconrel.2003.11.018","volume":"95","author":"CG Mill\u00e1n","year":"2004","unstructured":"Mill\u00e1n, C. G. et al. Drug, enzyme and peptide delivery using erythrocytes as carriers. J. Control. Release 95, 27\u201349 (2004).","journal-title":"J. Control. Release"},{"key":"28744_CR39","doi-asserted-by":"publisher","first-page":"eaaq1155","DOI":"10.1126\/scirobotics.aaq1155","volume":"2","author":"X Yan","year":"2017","unstructured":"Yan, X., Zhou, Q., Vincent, M., Deng, Y. & Zhang, L. Multifunctional biohybrid magnetite microrobots for imaging-guided therapy. Sci. Robot. 2, eaaq1155 (2017).","journal-title":"Sci. Robot."},{"key":"28744_CR40","doi-asserted-by":"publisher","first-page":"122628","DOI":"10.1016\/j.biortech.2019.122628","volume":"300","author":"W Chen","year":"2020","unstructured":"Chen, W., Xu, J. L., Yu, Q., Yuan, Z. H. & Guo, Y. Structural insights reveal the effective Spirulina platensis cell wall dissociation methods for multi-output recovery. Bioresour. Technol. 300, 122628 (2020).","journal-title":"Bioresour. Technol."},{"key":"28744_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2019\/3707219","volume":"2019","author":"R Seghiri","year":"2019","unstructured":"Seghiri, R., Kharbach, M. & Essamri, A. Functional composition, nutritional properties, and biological activities of moroccan spirulina microalga. J. Food Qual. 2019, 11 (2019).","journal-title":"J. Food Qual."},{"key":"28744_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/md14020027","volume":"14","author":"MF De Jesus Raposo","year":"2016","unstructured":"De Jesus Raposo, M. F., de Morais, A. M. & de Morais, R. M. Emergent sources of prebiotics: seaweeds and microalgae. Mar. Drugs 14, 27 (2016).","journal-title":"Mar. Drugs"},{"key":"28744_CR43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fcimb.2019.00243","volume":"9","author":"J Hu","year":"2019","unstructured":"Hu, J. et al. Dose effects of orally administered spirulina suspension on colonic microbiota in healthy mice. Front. Cell Infect. Microbiol. 9, 243 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"28744_CR44","doi-asserted-by":"publisher","first-page":"e1000879","DOI":"10.1371\/journal.ppat.1000879","volume":"6","author":"MJ van Vliet","year":"2010","unstructured":"van Vliet, M. J., Harmsen, H. J., de Bont, E. S. & Tissing, W. J. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog. 6, e1000879 (2010).","journal-title":"PLoS Pathog."},{"key":"28744_CR45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/apt.12878","volume":"40","author":"Y Touchefeu","year":"2014","unstructured":"Touchefeu, Y. et al. Systematic review: the role of the gut microbiota in chemotherapy\u2010 or radiation\u2010induced gastrointestinal mucositis\u2014current evidence and potential clinical applications. Aliment. Pharm. Ther. 40, 409\u2013421 (2014).","journal-title":"Aliment. Pharm. Ther."},{"key":"28744_CR46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrmicro2974","volume":"11","author":"F Sommer","year":"2013","unstructured":"Sommer, F. & B\u00e4ckhed, F. The gut microbiota-masters of host development and physiology. Nat. Rev. Microbiol. 11, 227\u2013238 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"28744_CR47","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21, 895\u2013905 (2015).","journal-title":"Nat. Med."},{"key":"28744_CR48","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/nmo.12378","volume":"26","author":"A Naseribafrouei","year":"2014","unstructured":"Naseribafrouei, A. et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol. Motil. 26, 1155\u20131162 (2014).","journal-title":"Neurogastroenterol. Motil."},{"key":"28744_CR49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/ismej.2010.92","volume":"5","author":"A Giongo","year":"2011","unstructured":"Giongo, A. et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5, 82\u201391 (2011).","journal-title":"ISME J."},{"key":"28744_CR50","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027\u20131031 (2006).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28744-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T18:04:45Z","timestamp":1700330685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28744-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28744"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28744-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,17]]},"assertion":[{"value":"21 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1413"}}